Hi Cal. Here's what vanished.
SUBJECT: Beckys Shares/SaltnPeppa Posted By: Beckysboss
Post Time: 2/4/02 14:00
« Previous Message Next Message »
Guess you missed my post, it isn't conjecture on my part or anyone elses for that matter.
Insider trading reports(unless you don't believe them) list Becky as having sold 1.15 million shares privately (Nov 17th) two days before she issued the Presidents message (Nov 19th) boosting the stock price by 51%. Obviously you choose to sell at the low ($3.35) to minimize capital gains, why you choose to sell at this point in time is another question. It raises ethical concerns to me when a CEO sells privately on Saturday then issues a new website message (not a NR) regarding FDA the following Monday which moves the stock from the low ($3.35) to over $5 in a two hour period. I thought it strange a NR was not used to inform shareholders of the FDA information , seems even stranger given the context of this 'private' share sale just two days earlier. Who knows who profited from this, given what we do know.
If it quacks , waddles when it walks and swims in water I would call it a duck, same goes for circumstances such as this until someone gives me a logical answer.
Trdate Repdate Tp Reln Shares Price Holdings Security - Relation
Keeler, Rebecca E.
19950222 19951231 30 45 36364 1.10 1305980 DIMETHAID RESEARCH COMMON -
19950306 19951231 95 45 114545 1.75 1420525 DIMETHAID RESEARCH COMMON -
19960109 19961231 20 45 -200000 0.85 1475859 DIMETHAID RESEARCH COMMON -
19960223 19961231 30 45 44444 0.90 1464969 DIMETHAID RESEARCH COMMON -
19960404 19961231 95 45 210890 0.87 1675859 DIMETHAID RESEARCH COMMON -
19960917 19961231 95 45 100000 3.25 1575859 DIMETHAID RESEARCH COMMON -
19970226 19981231 30 45 21538 3.25 1785380 DIMETHAID RESEARCH COMMON -
19970228 19981231 76 45 20000 4.00 1595859 DIMETHAID RESEARCH COMMON -
19970228 19981231 30 45 27027 1.48 1622886 DIMETHAID RESEARCH COMMON -
19970529 19981231 95 45 90956 0.00 1763842 DIMETHAID RESEARCH COMMON -
19971219 19981231 76 45 50000 0.50 1672886 DIMETHAID RESEARCH COMMON -
19980507 19981231 96 45 70000 3.18 1867329 DIMETHAID RESEARCH OPTIONS -
19980529 19981231 95 45 31949 3.13 1817329 DIMETHAID RESEARCH COMMON -
19990219 19991026 30 45 19763 2.53 1887092 DIMETHAID RESEARCH COMMON -
19990526 19991026 96 45 150000 3.50 2057092 DIMETHAID RESEARCH OPTIONS -
19990712 19991026 76 45 400000 2.50 1867329 DIMETHAID RESEARCH COMMON -
19990712 19991026 20 45 -400000 2.50 1867329 DIMETHAID RESEARCH COMMON -
20000218 20000606 95 45 11364 4.40 1668456 DIMETHAID RESEARCH COMMON -
20000417 20000606 96 45 100000 5.35 1778456 DIMETHAID RESEARCH OPTIONS -
20000905 20000926 98 45 0 0.00 440000 DIMETHAID RESEARCH OPTIONS -
20000905 20000926 98 45 0 0.00 1328456 DIMETHAID RESEARCH COMMON -
20010216 20010704 30 45 7342 6.81 1335798 DIMETHAID RESEARCH COMMON -
20010504 20010704 96 45 70000 5.95 510000 DIMETHAID RESEARCH OPTIONS -
20010711 20010828 76 45 -100000 3.25 410000 DIMETHAID RESEARCH OPTIONS -
20010711 20010828 20 45 -100000 5.80 1335798 DIMETHAID RESEARCH COMMON -
20011117 20011228 20 45 -1155798 3.35 180000 DIMETHAID RESEARCH COMMON -
Trade Fields
Trdate - Date that the insider made the trade
Repdate - Date the report was published by the OSC or BCSC
Tp - Transaction type - 2 digit code indicating the nature of the transaction
Reln - A 4-digit code for insider-issuer relationship
Shares - Number of securities acquired or disposed of by the insider. A sell is shown as
negative.
Price - The reported transaction price per security
Holdings - The reported holdings of the insider after the transaction
Security - Full security name
Code Description
00 Initial report of an Insider
10 Purchase or sale carried out in market, excluding exercise of an option
11 Private placement (issuance from treasury)
20 Purchase or sale carried out privately
22 Acquisition or disposition pursuant to a take-over bid
25 Change in nature of ownership
30 Acquisition or disposition under a plan
33 Balance unchanged
35 Stock dividend
40 Purchase or sale of a call option
45 Purchase or sale of a put option
46 Expiration of an option
50 Acquisition of disposition by gift
55 Acquisition by inheritance or by disposition by bequest
60 Short sale
65 Grant of warrants
66 Grant of rights
70 Exercise of warrants
71 Expiration of warrants
75 Exercise of rights
76 Exercise of options
78 Conversion or exchange
82 Capital reorganization
84 Stock split or consolidation
85 Redemption - cancellation
87 Issuer bid
90 Compensation for property
95 Compensation for services
96 Grant of options
97 Other (than referred to above)
98 Not supplied
99 Correction of information (amended report)
Relation - A 4-digit code for insider-issuer relationship Each digit (other than 0) represents a
relationship. Therefore, we can
describe up to 4 relationships with this field. The codes are as follows:
Code Description
1 Reporting issuer which as acquired securities issued by itself
(or, under the Canada Business Corporation Act, by any of its affiliates.
2 Subsidiary of the reporting issuer.
3 Security holder who beneficially owns or who exercises control or direction
over more than 10% of the securities of the reporting issuer (or, under the
Bank Act and in Quebec, 10% of a class of shares) to which are attached
voting rights or an unlimited right to a share of the profits and in its
assets in case of winding-up.
4 Director of a reporting issuer.
5 Senior officer of a reporting issuer.
6 Director or senior officer of a security holder referred to in 3 above.
7 Director or senior officer of an affiliate (or, under the Bank Act and
in Quebec, a subsidiary) of the reporting issuer, other than in 4,5, and 6 above.
8 Deemed an insider under the Canada Business Corporations Act or the Bank Act.
BCSC Report Codes
(Rel'n) Relationship with Issuer (more than one code may apply):
1. Reporting issuer that has acquired securities issued by itself (or by
any of its affiliates - CBCA).
2. Subsidiary of the reporting issuer.
3. Security holder who beneficially owns or who exercises control or
direction over more than 10% of the securities of the reporting
issuer (Bank Act, CCAA, ICA, TLCA, CBCA, and Quebec Securities Act -
10% of a class of shares) to which are attached voting rights or an
unlimited right to a share of the profits and to its assets in case
of winding up.
4. Director of a reporting issuer.
5. Senior officer of a reporting issuer.
6. Director or senior officer of a security holder referred to in 3.
7. Director or senior officer of an affiliate (Bank Act, CCAA, ICA, TLCA
and CBCA) or of a subsidiary of the reporting issuer, other than in
4, 5 and 6.
8. Deemed insider under the Bank Act, CCAA, ICA, TLCA and CBCA.
(Sec. Class) Security Class
BD Bonds RT Rights
CA Class A Shares UT Units
CB Class B Shares WT Warrants
CC Class C Shares SW Special Warrants
CM Common Shares IN Installment Receipts
DB Debentures CF Class F Shares
DD Dividends IR Initial Report
OP Options * Amended Report
PF Preferred Shares
(Nature) Nature of Ownership
0 Direct Ownership
1 Indirect Ownership (identify the registered holder)
2 Control or Direction (identify the registered holder)
Nature of Transaction
10 Acquisition or disposition carried out in the market, excluding the
exercise of an option
11 Private placement (issuance from treasury)
20 Acquisition or disposition carried out privately (already issued
securities)
22 Acquisition or disposition pursuant to a takeover bid or issuer
bid
25 Change in the nature of ownership
30 Acquisition or disposition under a plan
35 Stock dividend
40 Acquisition or disposition of a call option
45 Acquisition or disposition of a put option
46 Expiration of an option
50 Acquisition or disposition by gift
55 Acquisition by inheritance or disposition by bequest
60 Short sale
65 Grant of warrants
66 Grant of rights
70 Exercise of warrants
71 Expiration of warrants
72 Expiration of rights
75 Exercise of rights
76 Exercise of options
78 Conversion or exchange
84 Stock split or consolidation
85 Redemption/retraction/cancellation/repurchase
90 Compensation for property
95 Compensation for services
96 Grant of options
97 Other than referred to above (please explain in Remarks)
99 Correction of information (please explain in Remarks) |
